Thinking about cancer or dealing with cancer risk can be scary or overwhelming, but we believe that receiving information and resources is comforting, empowering, and lifesaving.
Breast Cancer Immunotherapy Update
February 2018 webinar on updates in Immunotherapy for breast cancer treatment.
A new type of cancer “vaccine” eliminates tumors in mice
XRAYS article about a new type of immunotherapy where the treatment is injected directly into the tumor.
Why I Chose Immunotherapy for Pancreatic Cancer
Thoughts from FORCE blog by pancreatic cancer survivor David Dessert.
Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors
Information from our clinical trial matching tool on a study looking at a combination of a PARP inhibitor with an immunotherapy agent for treatment of advanced triple-negative or ER/PR-positive breast cancer, recurrent platinum sensitive ovarian cancer, castration resistant prostate cancer, non-small cell lung cancer and urothelial cancer.
Basser Center for BRCA Breakthroughs and Discoveries Panel
Update from 2017 Basser Center for BRCA Annual Symposium has overview on state of immunotherapy for hereditary cancers.
2017 ASCO Annual Meeting Highlights
Update from the 2017 ASCO conference contains a section "Cancer immunotherapy brings new hope for breast cancer patients" with results from the ISPY trial.
Clinical Trial Looks at Combining Cancer Vaccine and Chemotherapy for Metastatic Breast Cancer Patients
XRAYS article on a clinical trial comparing the combination of PANVAC, an experimental cancer vaccine, and chemotherapy with docetaxel to the cancer vaccine alone in people with metastatic breast cancer.
Immunotherapy shows promise in triple-negative breast cancer
XRAYS review on 2017 presentation at AACR on immunotherapy for treatment of triple-negative breast cancer
Cancer Support Community: Is Immunotherapy Right for You?
Cancer Support Community website comprehensive Information on immunotherapy.
Patient Guide on Immunotherapy Side Effects
Immunotherapies have very specific side effects that make them different from other cancer treatments. This guide from the European Society of Medical Oncology (ESMO) provides an overview in patient-friendly language.